See also this year's filing and all EDGAR filings for this company.
PDF Report 0001623526_2021_Stoke_Therapeutics_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001623526')"} |
Graph
Absolute values for 0001623526, Stoke Therapeutics Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 293,930,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 2,675,000 |
3 | remainder_Assets | 1,320,000 |
4 | LiabilitiesCurrent | 11,425,000 |
5 | LiabilitiesNoncurrent | 422,000 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 20,847,000 |
9 | ResearchAndDevelopmentExpense | 32,197,000 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | 801,000 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 297,925,000 |
1 | Liabilities | 11,847,000 |
2 | Expenses | 53,044,000 |
3 | Revenues | 0 |
4 | StockholdersEquity | 286,078,000 |
5 | NetIncome | -52,243,000 |
6 | ComprehensiveNetIncome | -52,243,000 |
7 | BaseVar | 181,808,500 |
8 | EconomicCapitalRatio | 2.84 |